Daily Market Reports | May 09 2022
This story features ADORE BEAUTY GROUP LIMITED, and other companies. For more info SHARE ANALYSIS: ABY
An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
ABY AD8 (2) ALC ALL AT1 AX1 B4P BET CLU COF COH CRN CUV FCL (2) FMG GOR GOZ IPD JIN KED NCM NST NWS NXS OPY PBH PDN PLL QML REA RMS (2) RRL SES SGR SLA SLH TAH TSI WPR WSP Z2U
ABY ADORE BEAUTY GROUP LIMITED
Household & Personal Products – Overnight Price: $1.45
Shaw and Partners rates ((ABY)) as Buy (1) –
Adore Beauty was able to provide Q3 results slightly above Shaw and Partners expectations, despite elevated numbers a year earlier and significant reinvestment into new channels.
The broker noted increased cost inflation from supply chain disruptions remains a headwind and the longer-term growth outlook appears to be softening compared to the last 3 years.
The stock is seen trading at a -22% discount to listed pure online peers, based on estimates. There are no changes to forecasts, risk rating or price target.
A Buy rating is maintained. Target $3.50.
This report was published on April 29, 2022.
Target price is $3.50 Current Price is $1.45 Difference: $2.05
If ABY meets the Shaw and Partners target it will return approximately 141% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of 3.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 46.77.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 0.00 cents and EPS of 5.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.58.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AD8 AUDINATE GROUP LIMITED
Hardware & Equipment – Overnight Price: $5.63
Canaccord Genuity rates ((AD8)) as Buy (1) –
Audinate Group's Q3 FY22 trading update showed revenues were tracking ahead of Canaccord Genuity's forecasts and the impact of chip shortages were not impacting as much as expected.
The broker thinks the market will continue to focus on the supply-chain/chip availability as a constraint on growth. Audinate Group's order backlog remains at record levels, estimated as in excess of US$25m, which is expected to be cleared in Q4 FY22/FY23.
Management noted the Chinese lockdowns are a key risk for manufacturing production, particularly in the first half of FY23.
Canaccord Genuity has increased revenue and earnings forecasts. The price target was reduced to $8.00 from $9.00 as a higher discount rate has been applied to the valuation model.
A Buy rating is maintained.
This report was published on April 28, 2022.
Target price is $8.00 Current Price is $5.63 Difference: $2.37
If AD8 meets the Canaccord Genuity target it will return approximately 42% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Canaccord Genuity forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 0.09 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 6255.56.
Forecast for FY23:
Canaccord Genuity forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 0.07 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 8042.86.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Shaw and Partners rates ((AD8)) as Buy (1) –
Audinate Group's Q3 FY22 trading update was "rather surprisingly" positive according to Shaw and Partners.
Chip shortages peaked in January and February, with supply bouncing back in March, resulting in strong trading conditions in April.
Gross margin has been maintained and the chip inventory is now positive.
Shaw and Partners noted the improved ability for Audinate Group to be able to fulfill orders due to the rising supply of chips is being offset by manufacturing risks in China with covid lockdowns.
The broker's forecasts remain unchanged and the stock is rated a Buy; one to own for the long-term, suggests Shaw. Target $11.75.
This report was published on April 29, 2022.
Target price is $11.75 Current Price is $5.63 Difference: $6.12
If AD8 meets the Shaw and Partners target it will return approximately 109% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 4.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 137.32.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 2.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 225.20.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ALC ALCIDION GROUP LIMITED
Healthcare services – Overnight Price: $0.16
Canaccord Genuity rates ((ALC)) as Buy (1) –
Alcidion Group's Q3 FY22 trading report was in-line with Canaccord Genuity's expectations, booking revenues and cash burn in-line with forecasts.
The company is benefiting from unique tailwinds from the significant need for digitising patient records in UK hospitals, with about 30% of NHS trusts still using paper and pencil systems, the broker noted.
Alcidion Group's management and Canaccord Genuity are both confident the full year result will meet expectations. The company also continues to guide to underlying normalised earnings and cashflow breakeven for FY22.
A Buy rate is maintained and forecasts are unchanged. Target 32c.
This report was published on April 27, 2022.
Target price is $0.32 Current Price is $0.16 Difference: $0.16
If ALC meets the Canaccord Genuity target it will return approximately 100% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Canaccord Genuity forecasts a full year FY22 dividend of 0.00 cents and EPS of 0.00 cents.
Forecast for FY23:
Canaccord Genuity forecasts a full year FY23 dividend of 0.00 cents and EPS of 0.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 53.33.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ALL ARISTOCRAT LEISURE LIMITED
Gaming – Overnight Price: $32.14
Goldman Sachs rates ((ALL)) as Buy (1) –
Goldman Sachs reinstates coverage of Aristocrat Leisure with a $43 target and Buy rating. It's felt the business is positioned for longer-term structural growth, and medium term tailwinds should arise from ongoing design and development (D&D) investment.
Data also suggest to the broker the gaming environment is recovering quickly in the US beyond FY19 levels. In addition, due to a strong balance sheet, there's considered to be scope for either near-term capital management or M&A activity.
So far the diversification from land base to digital through a series of acquisitions has yielded benefits, with the analyst noting the strong performance of Pixel over the past two years.
This report was published on April 28, 2022.
Target price is $43.00 Current Price is $32.14 Difference: $10.86
If ALL meets the Goldman Sachs target it will return approximately 34% (excluding dividends, fees and charges).
Current consensus price target is $46.58, suggesting upside of 44.9%(ex-dividends)
The company's fiscal year ends in September.
Forecast for FY22:
Goldman Sachs forecasts a full year FY22 dividend of 66.00 cents and EPS of 163.00 cents.
At the last closing share price the estimated dividend yield is 2.05%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.72.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 153.5, implying annual growth of 19.8%.
Current consensus DPS estimate is 58.8, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 20.9.
Forecast for FY23:
Goldman Sachs forecasts a full year FY23 dividend of 73.00 cents and EPS of 183.00 cents.
At the last closing share price the estimated dividend yield is 2.27%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.56.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 177.2, implying annual growth of 15.4%.
Current consensus DPS estimate is 70.2, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 18.1.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AT1 ATOMO DIAGNOSTICS LIMITED
Medical Equipment & Devices – Overnight Price: $0.11
Canaccord Genuity rates ((AT1)) as Speculative Buy (1) –
Canaccord Genuity noted Atomo Diagnostics' Q3 FY22 revenue/receipts/OCF were better than expected with this quarters RAT sales outstripping the first half of FY22. This was the primary driver of the result.
The HIV result reflected the grind in the global procurement system but a better performance is expected going forward noted the broker.
To meet market expectations Atomo Diagnostics will need new revenue streams, better performance for the HIV business as well as FDA approval for FebriDX to fulfill the shortfall in RAT sales in FY23, says Canaccord Genuity.
A Speculative Buy rate is maintained with the broker concluding the market needs to see more from the company before the shares are re-rated. Target 25c.
This report was published on April 27, 2022.
Target price is $0.25 Current Price is $0.11 Difference: $0.14
If AT1 meets the Canaccord Genuity target it will return approximately 127% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AX1 ACCENT GROUP LIMITED
Apparel & Footwear – Overnight Price: $1.31
Wilsons rates ((AX1)) as Overweight (1) –
Accent Group's trading update suggested sales have improved but remain subdued since the first eight weeks of the second half FY22 according to Wilsons.
Management confirmed Accent Group's gross margins improved over last year and the broker expects lower second half revenue to be offset by higher gross margins.
Wilsons is encouraged by the transition of PIVOT stores into proven, higher gross margin retail banners, with the strategy showing a clear focus on the youth apparel market to increase market shares and margin expansion.
The company did not provide any guidance and the broker's earnings forecasts were raised slightly +0.5% in FY22 and +0.1% FY23.
The stock is Overweight rated. Target $2.20.
This report was published on April 29, 2022.
Target price is $2.20 Current Price is $1.31 Difference: $0.89
If AX1 meets the Wilsons target it will return approximately 68% (excluding dividends, fees and charges).
Current consensus price target is $2.23, suggesting upside of 70.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Wilsons forecasts a full year FY22 dividend of 6.30 cents and EPS of 7.50 cents.
At the last closing share price the estimated dividend yield is 4.81%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.47.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 9.4, implying annual growth of -33.8%.
Current consensus DPS estimate is 8.4, implying a prospective dividend yield of 6.4%.
Current consensus EPS estimate suggests the PER is 13.9.
Forecast for FY23:
Wilsons forecasts a full year FY23 dividend of 10.70 cents and EPS of 12.80 cents.
At the last closing share price the estimated dividend yield is 8.17%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.23.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 14.7, implying annual growth of 56.4%.
Current consensus DPS estimate is 12.3, implying a prospective dividend yield of 9.4%.
Current consensus EPS estimate suggests the PER is 8.9.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
B4P BEFOREPAY GROUP LIMITED
Diversified Financials – Overnight Price: $0.40
Shaw and Partners rates ((B4P)) as Initiation of coverage with Buy (1) –
Shaw and Partners' viewed the Q3 FY22 Beforepay Group trading update as delivering on the continued strong momentum from the 1H22.
Active users, average pay advance and sales were all above the broker's forecasts.
Beforepay has cash of $35m which is 1.5x the market capitalisation. Customer loyalty also seems to be staying strong according to Shaw and Partners.
The stock is Buy rated, trading at a deep discount based on the broker's forecasts to the credit provider segment and the BNPL sector of -80% and -84%, respectively. Target $2.
This report was published on April 29, 2022.
Target price is $2.00 Current Price is $0.40 Difference: $1.6
If B4P meets the Shaw and Partners target it will return approximately 400% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 47.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 0.85.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 24.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 1.66.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
BET BETMAKERS TECHNOLOGY GROUP LIMITED
Gaming – Overnight Price: $0.49
Sequoia rates ((BET)) as Buy (1) –
Betmakers Technology has announced a major joint-venture deal with News Corp ((NWS)) and Sequoia says this, combined with acquisitions in the past year, have considerably improved the company's prospects..
The broker says the June 2021 purchase pf Sportech PLC's Tote and digital assets provided critical mass.
The company has now announced a 10-year joint-venture contract with News Corp to provide a turnkey wagering solution to a new Sportsbetting consortium between News Corp, TGW and Tekkorp – set to launch in six months.
Buy rating retained. Target price jumps to 91c from 77c.
This report was published on April 26, 2022.
Target price is $0.91 Current Price is $0.49 Difference: $0.42
If BET meets the Sequoia target it will return approximately 86% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Sequoia forecasts a full year FY22 dividend of 0.00 cents and EPS of 0.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 245.00.
Forecast for FY23:
Sequoia forecasts a full year FY23 dividend of 0.00 cents and EPS of 1.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 40.83.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CLU CLUEY LIMITED
Education & Tuition – Overnight Price: $0.93
Canaccord Genuity rates ((CLU)) as Buy (1) –
Cluey reported another strong result with Q3 FY22 revenue +120% on the year before noted Canaccord Genuity.
In the broker's view Q4 FY22 will mark a milestone as Cluey is on track for breakeven cash flows on a monthly basis and all the key operational metrics were in-line with expectations.
The company has launched a number of key growth initiatives (two secondary subjects, piloting Code Camp UK in Q4 FY22 and lifting investment in NZ) and is well capitalised with $28m in net cash, noted the broker.
Canaccord Genuity considers Cluey to be one of the fastest growing companies on the ASX as it attempts to take meaningful market share gains in a $4bn total addressable market (TAM) (annually).
Nevertheless the broker notes loss making companies are 'not in vogue'.
A Buy rating is maintained and the DCF valuation has been reduced to $1.70 from $2.00
This report was published on April 28, 2022.
Target price is $1.70 Current Price is $0.93 Difference: $0.77
If CLU meets the Canaccord Genuity target it will return approximately 83% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
COF CENTURIA OFFICE REIT
REITs – Overnight Price: $2.13
Moelis rates ((COF)) as Buy (1) –
Centuria Office REIT's March-quarter result revealed strong leasing outcomes, says Moelis, the amount of space due for expiry prior to June 23 reducing, and derisking the group's income profile.
Occupancy was steady at 94.1% and management retains guidance.
Moelis attributes share-price weakness to covid-induced office-leasing challenges and expects it will recover as tenant demand returns.
Buy rating retained, the broker considering the share price to be very attractive, the company trading at a -10% discount to net tangible assets, plus Moelis appreciates the 7.5% dividend yield. Target price steady at $2.53.
This report was published on May 1, 2022.
Target price is $2.53 Current Price is $2.13 Difference: $0.4
If COF meets the Moelis target it will return approximately 19% (excluding dividends, fees and charges).
Current consensus price target is $2.51, suggesting upside of 17.7%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Moelis forecasts a full year FY22 dividend of 16.60 cents and EPS of 18.30 cents.
At the last closing share price the estimated dividend yield is 7.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.64.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.1, implying annual growth of 21.6%.
Current consensus DPS estimate is 16.7, implying a prospective dividend yield of 7.8%.
Current consensus EPS estimate suggests the PER is 11.8.
Forecast for FY23:
Moelis forecasts a full year FY23 dividend of 16.80 cents and EPS of 18.50 cents.
At the last closing share price the estimated dividend yield is 7.89%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.51.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.9, implying annual growth of 4.4%.
Current consensus DPS estimate is 17.1, implying a prospective dividend yield of 8.0%.
Current consensus EPS estimate suggests the PER is 11.3.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
COH COCHLEAR LIMITED
Medical Equipment & Devices – Overnight Price: $219.39
Goldman Sachs rates ((COH)) as Buy (1) –
Following Cochlear's announcement it will be acquiring Oticon Medical for -$170m, Goldman Sachs sees a number of positives.
While Cochlear's market share will only increase by around 3%, its market position will be entrenched with greater scale, allowing further re-investment into product development, explains the broker.
Also, as Oticon had previously pitched its pricing below the industry average, the analyst believes the transaction could support overall pricing.
The Buy rating and $237 target price are maintained.
This report was published on April 28, 2022.
Target price is $237.00 Current Price is $219.39 Difference: $17.61
If COH meets the Goldman Sachs target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $227.58, suggesting upside of 3.7%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Goldman Sachs forecasts a full year FY22 EPS of 452.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 48.54.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 427.7, implying annual growth of -13.9%.
Current consensus DPS estimate is 290.0, implying a prospective dividend yield of 1.3%.
Current consensus EPS estimate suggests the PER is 51.3.
Forecast for FY23:
Goldman Sachs forecasts a full year FY23 EPS of 495.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 44.32.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 479.0, implying annual growth of 12.0%.
Current consensus DPS estimate is 329.4, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 45.8.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CRN CORONADO GLOBAL RESOURCES INC
Coal – Overnight Price: $2.26
Goldman Sachs rates ((CRN)) as Buy (1) –
First quarter saleable coal production increased by 4% for Coronado Global Resources, a 3% beat versus Goldman Sachs estimate, while the realised met coal price of US$267/t exceeded the broker's US$253/t forecast.
Management left FY22 production guidance unchanged and stated acquisition opportunities will be explored, given the strong balance sheet.
The company expects a positive impact from the recently announced EU embargo on Russian coal, which comes into effect during August. The Buy rating and $3.00 target price are maintained.
This report was published on April 28, 2022.
Target price is $3.00 Current Price is $2.26 Difference: $0.74
If CRN meets the Goldman Sachs target it will return approximately 33% (excluding dividends, fees and charges).
Current consensus price target is $3.14, suggesting upside of 39.1%(ex-dividends)
The company's fiscal year ends in December.
Forecast for FY22:
Goldman Sachs forecasts a full year FY22 dividend of 86.98 cents and EPS of 123.13 cents.
At the last closing share price the estimated dividend yield is 38.49%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 1.84.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 96.6, implying annual growth of N/A.
Current consensus DPS estimate is 49.7, implying a prospective dividend yield of 22.0%.
Current consensus EPS estimate suggests the PER is 2.3.
Forecast for FY23:
Goldman Sachs forecasts a full year FY23 dividend of 36.70 cents and EPS of 41.32 cents.
At the last closing share price the estimated dividend yield is 16.24%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.47.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 52.3, implying annual growth of -45.9%.
Current consensus DPS estimate is 36.8, implying a prospective dividend yield of 16.3%.
Current consensus EPS estimate suggests the PER is 4.3.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CUV CLINUVEL PHARMACEUTICALS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $15.57
Wilsons rates ((CUV)) as No Rating (-1) –
Clinuvel Pharmaceuticals Appendix 4C release for Q3 FY22 showed total cash receipts of $11.4m, up 75% from last year. Wilsons noted that last year was a Covid impacted period. The expenditures were inline with the broker's forecasts at $7.4m.
Wilsons noted the cash balance stands at $101.9m with no net debt on the balance sheet which the broker feels will support the Clinuvel Pharmaceuticals' active clinical programs.
The Q3 cash receipts support the broker's forecasts for FY22 revenue and expenses. The current investment rating and price target are under review.
This report was published on April 28, 2022.
Current Price is $15.57. Target price not assessed.
The company's fiscal year ends in June.
Forecast for FY22:
Wilsons forecasts a full year FY22 dividend of 5.50 cents and EPS of 65.90 cents.
At the last closing share price the estimated dividend yield is 0.35%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.63.
Forecast for FY23:
Wilsons forecasts a full year FY23 dividend of 5.90 cents and EPS of 78.20 cents.
At the last closing share price the estimated dividend yield is 0.38%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.91.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
FCL FINEOS CORPORATION HOLDINGS PLC
Cloud services – Overnight Price: $1.93
Moelis rates ((FCL)) as Buy (1) –
Fineos Corp's March-quarter trading update disappointed Moelis, management saying budget issues for insurance carriers was suppressing new wins, and the broker lowers software sales estimates in FY23 and FY24.
Moelis suspects conditions will slowly return to pre-covid levels by FY24.
Buy rating retained, the broker admiring Fineos' leading market position, strong subscription sales and -35% discount to insurtech peers.
Target price falls to $3.36 from $4.04 to reflect continuing tech-sector de-ratings.
This report was published on May 2, 2022.
Target price is $3.36 Current Price is $1.93 Difference: $1.43
If FCL meets the Moelis target it will return approximately 74% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Moelis forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 3.28 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 58.81.
Forecast for FY23:
Moelis forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 1.41 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 137.27.
This company reports in EUR. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Shaw and Partners rates ((FCL)) as Buy (1) –
Fineos Corp released its Q3 FY22 trading update and Shaw and Partners noted cash receipts were strong again, no new customers were signed and the company signed a strategic alliance with EY Business Consultants Ireland.
The company did highlight "encouraging milestones across our regions from successful go lives, to SI alliance developments".
The broker noted Fineos did not provide a guidance update. The last guidance in 1H22 expects FY22 revenue at the low-end of EUR123-130m and subscription revenue of 30%
Shaw and Partners maintained a Buy rating and noted the company is trading at a discount to US peers. Target $3.40.
This report was published on April 29, 2022.
Target price is $3.40 Current Price is $1.93 Difference: $1.47
If FCL meets the Shaw and Partners target it will return approximately 76% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 5.31 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 36.33.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 3.13 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 61.76.
This company reports in EUR. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
FMG FORTESCUE METALS GROUP LIMITED
Iron Ore – Overnight Price: $20.83
Shaw and Partners rates ((FMG)) as Hold (3) –
Fortescue Metals' Q3 FY22 results were strong across all key metrics, says Shaw and Partners.
The broker highlighted the company had record shipments (46.5mt) and the results were strong across port, rail and mining, bringing the YTD total to 139mt.
The company upgraded FY guidance to 185-188mt, up by 4mt. Costs rose with headwinds from global inflation pressures – labour, energy, raw materials and freight, the broker highlighted, which will cap some of the positive growth contribution from record shipments.
On balance, the broker increased costs by 3% for FY22.
Shaw and Partners rates the stock Hold. Target $17.
This report was published on April 29, 2022.
Target price is $17.00 Current Price is $20.83 Difference: minus $3.83 (current price is over target).
If FMG meets the Shaw and Partners target it will return approximately minus 18% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $18.22, suggesting downside of -12.5%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 285.81 cents and EPS of 260.94 cents.
At the last closing share price the estimated dividend yield is 13.72%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.98.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 291.9, implying annual growth of N/A.
Current consensus DPS estimate is 209.5, implying a prospective dividend yield of 10.1%.
Current consensus EPS estimate suggests the PER is 7.1.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 249.52 cents and EPS of 221.53 cents.
At the last closing share price the estimated dividend yield is 11.98%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.40.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 264.2, implying annual growth of -9.5%.
Current consensus DPS estimate is 184.2, implying a prospective dividend yield of 8.8%.
Current consensus EPS estimate suggests the PER is 7.9.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
GOR GOLD ROAD RESOURCES LIMITED
Gold & Silver – Overnight Price: $1.43
Canaccord Genuity rates ((GOR)) as Buy (1) –
Canaccord Genuity noted the March quarter 2022 production report for Gold Road Resources was in-line with expectations and a beat on costs.
Gruyere produced 71.1koz +5% on the last quarter, in-line with the broker's estimates and consensus. The improvement on the previous quarter was due to better head grades and throughput despite two scheduled plant shutdowns, the broker noted.
Gold Road Resources recently made an off-market (all scrip) takeover for DGO Gold (DGO), which is supported by the DGO board. DGO holds equit stakes in a number of ASX-listed gold companies as well as a number of greenfield exploration projects. Canaccord Genuity thinks this is a well considered move by the company.
The broker lowered the price target to $2.20 from $2.30 based on the March quarter results with higher input mining costs (diesel, reagents, freight and labour) and reduced assumed recoveries to 91% from 92%.
A Buy rating is maintained.
This report was published on April 27, 2022.
Target price is $2.20 Current Price is $1.43 Difference: $0.77
If GOR meets the Canaccord Genuity target it will return approximately 54% (excluding dividends, fees and charges).
Current consensus price target is $1.80, suggesting upside of 25.9%(ex-dividends)
The company's fiscal year ends in December.
Forecast for FY22:
Canaccord Genuity forecasts a full year FY22 dividend of 0.02 cents and EPS of 0.11 cents.
At the last closing share price the estimated dividend yield is 0.01%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 1300.00.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 10.5, implying annual growth of 151.2%.
Current consensus DPS estimate is 1.2, implying a prospective dividend yield of 0.8%.
Current consensus EPS estimate suggests the PER is 13.6.
Forecast for FY23:
Canaccord Genuity forecasts a full year FY23 dividend of 0.04 cents and EPS of 0.14 cents.
At the last closing share price the estimated dividend yield is 0.03%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 1021.43.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 12.7, implying annual growth of 21.0%.
Current consensus DPS estimate is 1.0, implying a prospective dividend yield of 0.7%.
Current consensus EPS estimate suggests the PER is 11.3.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
GOZ GROWTHPOINT PROPERTIES AUSTRALIA
Infra & Property Developers – Overnight Price: $3.98
Moelis rates ((GOZ)) as Downgrade to Hold from Buy (3) –
Growthpoint Properties Australia executed eight leases across its portfolio in the third quarter, with Moelis noting leases accounted for 6% of portfolio income, and entered into two new 10-year deals. Further, weighted average lease expiry increased to 6.4 years from 6.3 years.
The broker notes low vacancy and strong tenant demand look set to continue to support high levels of transaction activity in industrial markets, and expects office space to experience steady recovery as workers return.
The rating is downgraded to Hold from Buy and the target price increases to $4.56 from $4.47.
This report was published on April 28, 2022.
Target price is $4.56 Current Price is $3.98 Difference: $0.58
If GOZ meets the Moelis target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is $4.53, suggesting upside of 13.8%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Moelis forecasts a full year FY22 dividend of 20.80 cents and EPS of 27.30 cents.
At the last closing share price the estimated dividend yield is 5.23%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.58.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 25.3, implying annual growth of -64.7%.
Current consensus DPS estimate is 20.9, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 15.7.
Forecast for FY23:
Moelis forecasts a full year FY23 dividend of 21.30 cents and EPS of 28.20 cents.
At the last closing share price the estimated dividend yield is 5.35%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.11.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 26.0, implying annual growth of 2.8%.
Current consensus DPS estimate is 22.0, implying a prospective dividend yield of 5.5%.
Current consensus EPS estimate suggests the PER is 15.3.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
IPD IMPEDIMED LIMITED
Medical Equipment & Devices – Overnight Price: $0.11
Wilsons rates ((IPD)) as Overweight (1) –
Impedimed's Q3 FY22 reported sales of $2.7m which was below Wilsons' expectations.
The broker noted the quarter was impacted by Omicron, reducing hospital access and affecting device placement and patient testing.
SaaS revenue climbed 29% to $2.3m which supported the trading results and the 100% increase in cashflow resulted from the withholding of employee short term incentives until after the PREVENT trial publication.
Wilsons did not change forecasts and the price target remains at $0.30. This latest update contains no rating, but our database shows the last rating published by Wilsons was Overweight.
This report was published on April 28, 2022.
Target price is $0.30 Current Price is $0.11 Difference: $0.19
If IPD meets the Wilsons target it will return approximately 173% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
JIN JUMBO INTERACTIVE LIMITED
Gaming – Overnight Price: $16.97
Goldman Sachs rates ((JIN)) as Neutral (3) –
The latest domestic lottery trends suggest to Goldman Sachs a solid backdrop for the gaming industry with a strong positive read-through for Jumbo Interactive.
The shift to higher-margin digital and an upcoming OzLotto game change should result in upside for Lotteries, explains the analyst.
The broker increases its earnings forecasts for the company across FY22-24 by an average of 3%, given the stronger Lottery momentum. As a result, the target price rises to $18.00 from $17.40 and the Neutral rating remains.
This report was published on April 28, 2022.
Target price is $18.00 Current Price is $16.97 Difference: $1.03
If JIN meets the Goldman Sachs target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $20.13, suggesting upside of 18.6%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Goldman Sachs forecasts a full year FY22 EPS of 53.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.02.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 52.2, implying annual growth of 20.9%.
Current consensus DPS estimate is 42.9, implying a prospective dividend yield of 2.5%.
Current consensus EPS estimate suggests the PER is 32.5.
Forecast for FY23:
Goldman Sachs forecasts a full year FY23 EPS of 64.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.52.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 66.2, implying annual growth of 26.8%.
Current consensus DPS estimate is 49.1, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 25.6.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
KED KEYPATH EDUCATION INTERNATIONAL INC
Education & Tuition – Overnight Price: $1.64
Shaw and Partners rates ((KED)) as Buy (1) –
Keypath Education International released its Q3 FY22 cashflow and trading report, where the company noted it had experienced enrolment disruption in Australia due to omicron and flooding in NSW.
In response, Shaw and Partners reduced FY22 forecasts to in-line with the prospectus and the FY23 revenue by -3% to account for the enrolment delays.
The company reiterated FY22 guidance and break-even for FY24.
Shaw and Partners reiterated the Buy rating and left the price target unchanged at $4.10, whilst noting the company is trading on FY22 EV/Revenue multiple of 1.9x.
The broker believes share price weakness offers a fantastic entry point to own a quality business.
This report was published on April 29, 2022.
Target price is $4.10 Current Price is $1.64 Difference: $2.46
If KED meets the Shaw and Partners target it will return approximately 150% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 8.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 19.07.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 5.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 32.16.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NCM NEWCREST MINING LIMITED
Gold & Silver – Overnight Price: $26.43
Shaw and Partners rates ((NCM)) as Buy (1) –
Newcrest Mining delivered a solid Q3 FY22 quarterly production and update according to Shaw and Partners.
The company reported Q3 gold production 480Koz versus 436Koz last quarter and copper production 21kt versus 22Kt a quarter ago.
Costs were lower by -$40/oz.
Shaw and Partners likes the results highlighting the solid production update, and the company's guidance to a better current quarter as well as upgraded production guidance and lower cost and capex guidance.
The broker also noted that global growth options are "looking more interesting". A Buy rating is maintained.
This report was published on April 29, 2022.
Target price is $32.00 Current Price is $26.43 Difference: $5.57
If NCM meets the Shaw and Partners target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $29.68, suggesting upside of 12.3%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 60.89 cents and EPS of 169.34 cents.
At the last closing share price the estimated dividend yield is 2.30%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.61.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 147.6, implying annual growth of N/A.
Current consensus DPS estimate is 21.1, implying a prospective dividend yield of 0.8%.
Current consensus EPS estimate suggests the PER is 17.9.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 42.81 cents and EPS of 179.67 cents.
At the last closing share price the estimated dividend yield is 1.62%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.71.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 188.9, implying annual growth of 28.0%.
Current consensus DPS estimate is 47.9, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 14.0.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NST NORTHERN STAR RESOURCES LIMITED
Gold & Silver – Overnight Price: $9.42
JP Morgan rates ((NST)) as Upgrade to Overweight from Neutral (1) –
Third quarter production for Northern Star Resources was a -7% miss versus JP Morgan's forecast, though management maintained full year guidance.
All-in sustaining costs (AISC) were an -8% miss due to mill maintenance at the Super Pit in Kalgoorlie and a change in development priorities at the Pogo gold mine in Alaska. Thus, management revised group cost guidance higher.
Despite a difficult quarter, the broker estimates solid valuation support and upgrades its rating to Overweight from Neutral after shares have taken a tumble since mid-March. The target price is reduced to $11 from $11.50.
This report was published on April 28, 2022.
Target price is $11.00 Current Price is $9.42 Difference: $1.58
If NST meets the JP Morgan target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $12.44, suggesting upside of 32.1%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
JP Morgan forecasts a full year FY22 dividend of 24.00 cents and EPS of 35.00 cents.
At the last closing share price the estimated dividend yield is 2.55%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.91.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 27.8, implying annual growth of -75.8%.
Current consensus DPS estimate is 23.0, implying a prospective dividend yield of 2.4%.
Current consensus EPS estimate suggests the PER is 33.9.
Forecast for FY23:
JP Morgan forecasts a full year FY23 dividend of 35.00 cents and EPS of 68.00 cents.
At the last closing share price the estimated dividend yield is 3.72%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.85.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 43.7, implying annual growth of 57.2%.
Current consensus DPS estimate is 26.6, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 21.6.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NWS NEWS CORPORATION
Print, Radio & TV – Overnight Price: $26.60
Goldman Sachs rates ((NWS)) as Buy (1) –
Goldman Sachs notes residential property listings have been better than expected to date in 2022, with third quarter listings up 12%. With April declining -4%, the broker anticipates a larger drop of -6% in May amid the Federal election.
Further, Goldman Sachs expects listings will decline over the next few years after the strong listings growth experienced in 2021 and early 2022.
Incorporating increased forecasts for year-on-year listings growth to 10% from 8% for REA Group ((REA)) and recent acquisitions, Goldman Sachs' earnings per share forecasts for News Corp declines -1-2%.
The Buy rating and target price of $41.30 are retained.
This report was published on April 27, 2022.
Target price is $41.30 Current Price is $26.60 Difference: $14.7
If NWS meets the Goldman Sachs target it will return approximately 55% (excluding dividends, fees and charges).
Current consensus price target is $41.88, suggesting upside of 57.4%(ex-dividends)
Forecast for FY22:
Current consensus EPS estimate is 116.4, implying annual growth of N/A.
Current consensus DPS estimate is 30.1, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 22.9.
Forecast for FY23:
Current consensus EPS estimate is 135.4, implying annual growth of 16.3%.
Current consensus DPS estimate is 31.9, implying a prospective dividend yield of 1.2%.
Current consensus EPS estimate suggests the PER is 19.6.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NXS NEXT SCIENCE LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.89
Wilsons rates ((NXS)) as No Rating (-1) –
Next Science's Q1 2022 trading update showed revenue growth up 31% since last year and net operating cashflow was down -US$2.85m due to the staffing costs associated with the XPerience launch and operations, noted Wilsons.
As at the end of the March quarter Next Science had US$12.2m in cash following a two-tranche capital raise with another US$4m in a third tranche expected in the second quarter of 2022, which is subject to shareholder approval at the May AGM, the broker noted.
Wilsons' price target and recommendation are under review. The last published rating, in April, was Overweight.
This report was published on April 28, 2022.
Current Price is $0.89. Target price not assessed.
The company's fiscal year ends in December.
Forecast for FY22:
Wilsons forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 4.35 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 20.46.
Forecast for FY23:
Wilsons forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 1.63 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 54.57.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
OPY OPENPAY GROUP LIMITED
Business & Consumer Credit – Overnight Price: $0.32
Shaw and Partners rates ((OPY)) as Buy (1) –
As Openpay Group's Q3 FY22 trading update was largely pre-announced on April 5 2022, there was little news for the official Q3 update according to Shaw and Partners.
The broker states the company delivered strong results despite the weaker seasonality of Q3 versus Q2. Revenue went up 62% to $7.5m versus Shaw and Partners' forecast $7.2m.
The broker noted the company is on track to achieve profitability in Australia and New Zealand in 15 months, with the cost base expected to reduce from Q4 after the US ramp-up.
A Buy rating is maintained. Price target $1.25.
This report was published on April 29, 2022.
Target price is $1.25 Current Price is $0.32 Difference: $0.93
If OPY meets the Shaw and Partners target it will return approximately 291% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 41.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 0.77.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 24.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 1.32.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
PBH POINTSBET HOLDINGS LIMITED
Gaming – Overnight Price: $2.84
JP Morgan rates ((PBH)) as Underweight (5) –
JP Morgan is cautious around the potential for a capital raising and the likelihood of disappointment at PointsBet Holdings' Australian operations from lower market share and less active customers.
In the US, the analyst is concerned about customer acquisition costs and the industry structure, which favours a duopoly. It's also noted the promotional spend for New York is much higher than average.
The Underweight rating is maintained, while the target price is reduced to $2.80 from $5.00.
This report was published on April 28, 2022.
Target price is $2.80 Current Price is $2.84 Difference: minus $0.04 (current price is over target).
If PBH meets the JP Morgan target it will return approximately minus 1% (excluding dividends, fees and charges – negative figures indicate an expected loss).
The company's fiscal year ends in June.
Forecast for FY22:
JP Morgan forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 83.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 3.42.
Forecast for FY23:
JP Morgan forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 102.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 2.78.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
PDN PALADIN ENERGY LIMITED
Uranium – Overnight Price: $0.74
Shaw and Partners rates ((PDN)) as Buy (1) –
Paladin Energy released its Q3 FY22 activity report. Shaw and Partners consider this as a pivotal quarter with the company in the process of completing a $215m equity raising and signing its first long-term contract with a leading US utility.
The broker finds the company is in a strong financial position after the equity raising with $259m in net cash on the balance sheet and fully funded for a Langer Heinrich restart (capital need US$87m).
Shaw and Partners considers Paladin Energy as the premium and most liquid name in the uranium sector on the ASX.
The Buy rating is maintained. Price target $1.30.
This report was published on April 29, 2022.
Target price is $1.30 Current Price is $0.74 Difference: $0.56
If PDN meets the Shaw and Partners target it will return approximately 76% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 0.41 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 181.37.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 0.14 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 544.12.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
PLL PIEDMONT LITHIUM INC
New Battery Elements – Overnight Price: $0.93
Canaccord Genuity rates ((PLL)) as Speculative Buy (1) –
Piedmont Lithium recently completed a preliminary economic assessment for the development of a second lithium hydroxide plant which uses the spodumene off take agreement to produce 30ktpa, noted Canaccord Genuity.
The initial capital costs of- US$572m would be supported by off take rights that the company has secured over the Abitibi Hub JV in Quebec and Ewoyya in Ghana.
Canaccord Genuity highlighted together with the existing plans for a fully integrated mine and 30ktpa refinery at Carolina, Piedmont Lithium's potential total capacity increases to 60kt.
The broker's modeling sees initial cash flow brought forward to 2023 and lower earnings post 2025 due to the higher costs of the second plant.
The target price is upgraded to $1.70 from $1.55 on updated estimates for Abitii/Ewoyya and the additional plant. A Speculative Buy is maintained.
This report was published on April 27, 2022.
Target price is $1.70 Current Price is $0.93 Difference: $0.77
If PLL meets the Canaccord Genuity target it will return approximately 83% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
QML QMINES LIMITED
Mining – Overnight Price: $0.28
Shaw and Partners rates ((QML)) as Buy (1) –
QMines Q3 FY22 activities report showed further excellent drill results at the Mount Chalmers project according to Shaw and Partners.
The results are considered to be positive for the upcoming resource update in a few weeks noted the broker, with the quality and confidence considerably improved with the last upgrade.
Shaw and Partners maintains a Buy rating. Price target 74c.
This report was published on April 29, 2022.
Target price is $0.74 Current Price is $0.28 Difference: $0.46
If QML meets the Shaw and Partners target it will return approximately 164% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 1.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 16.47.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 1.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 17.50.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
REA REA GROUP LIMITED
Real Estate – Overnight Price: $112.15
Goldman Sachs rates ((REA)) as Buy (1) –
Goldman Sachs notes residential property listings have been better than expected to date in 2022, with third quarter listings up 12%. With April declining -4%, the broker anticipates a larger drop of -6% in May amid the Federal election.
Further, Goldman Sachs expects listings will decline over the next few years after the strong listings growth experienced in 2021 and early 2022.
Incorporating increased forecasts for year-on-year listings growth to 10% from 8% for REA Group drives Goldman Sachs' earnings per share forecasts for the company up 1-4%.
The Buy rating is retained with a target price of $170.00.
This report was published on April 27, 2022.
Target price is $170.00 Current Price is $112.15 Difference: $57.85
If REA meets the Goldman Sachs target it will return approximately 52% (excluding dividends, fees and charges).
Current consensus price target is $162.19, suggesting upside of 44.6%(ex-dividends)
Forecast for FY22:
Current consensus EPS estimate is 316.7, implying annual growth of 29.5%.
Current consensus DPS estimate is 168.0, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 35.4.
Forecast for FY23:
Current consensus EPS estimate is 366.1, implying annual growth of 15.6%.
Current consensus DPS estimate is 197.0, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 30.6.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
RMS RAMELIUS RESOURCES LIMITED
Gold & Silver – Overnight Price: $1.41
Canaccord Genuity rates ((RMS)) as Buy (1) –
Canaccord Genuity noted Ramelius Resources reported a -12% miss in production for the Q3 FY22 due to the lower haulage availability from labour shortages.
The broker noted that since the border re-openings, the ore tonnes hauled increased by 46% in March compared to the previous two-month average.
Cash and gold were flat on the previous quarter at $164.7m and underlying cashflow missed the broker's forecasts by -$13m on the lower production.
The company has tightened FY22 guidance to 260-265koz, at the lower end of the prior range. This compares to Canaccord Genuity's forecast of 261koz.
The price target has been reduced to $2.40 from $2.50 adjusting for the 3Q trading update and higher cost forecasts.
A Buy rating has been maintained.
This report was published on April 28, 2022.
Target price is $2.40 Current Price is $1.41 Difference: $0.99
If RMS meets the Canaccord Genuity target it will return approximately 70% (excluding dividends, fees and charges).
Current consensus price target is $1.74, suggesting upside of 23.2%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Current consensus EPS estimate is 8.7, implying annual growth of -44.4%.
Current consensus DPS estimate is 0.6, implying a prospective dividend yield of 0.4%.
Current consensus EPS estimate suggests the PER is 16.2.
Forecast for FY23:
Current consensus EPS estimate is 11.4, implying annual growth of 31.0%.
Current consensus DPS estimate is 2.3, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 12.4.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Shaw and Partners rates ((RMS)) as Buy (1) –
Ramelius Resources released its Q3 FY22 activities report which showed the weakest production in two years, largely due to the Covid work shortages and the planned mill maintenance in March, noted Shaw and Partners.
The company guided production lower to 260-265koz, the low-end of the previously announced range of 260-300koz.
Shaw and Partners credited the company for being able ro still expect to report costs and production within the original guidance despite the Covid challenges, rising energy costs and higher inflation.
The broker has revised down the profit forecasts by -16% and -15% for FY22 and FY23, respectively, based on a lower expected gold price and the impact of higher costs and lower production.
Shaw lowers the price target to $2.35 from $2.49 and a Buy rating is maintained.
This report was published on April 29, 2022.
Target price is $2.35 Current Price is $1.41 Difference: $0.94
If RMS meets the Shaw and Partners target it will return approximately 67% (excluding dividends, fees and charges).
Current consensus price target is $1.74, suggesting upside of 23.2%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 4.00 cents and EPS of 14.20 cents.
At the last closing share price the estimated dividend yield is 2.84%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.93.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 8.7, implying annual growth of -44.4%.
Current consensus DPS estimate is 0.6, implying a prospective dividend yield of 0.4%.
Current consensus EPS estimate suggests the PER is 16.2.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 5.00 cents and EPS of 17.40 cents.
At the last closing share price the estimated dividend yield is 3.55%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.10.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 11.4, implying annual growth of 31.0%.
Current consensus DPS estimate is 2.3, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 12.4.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
RRL REGIS RESOURCES LIMITED
Gold & Silver – Overnight Price: $1.96
Shaw and Partners rates ((RRL)) as Buy (1) –
Regis Resources experienced Garden Well maintenance delays due to Covid absenteeism and delayed border opening to receive materials noted Shaw and Partners.
The broker expects a much better outlook for the June quarter after the well flagged weakness in Q3 which should allow the company to meet its FY22 guidance.
Shaw and Partners feels there is share price support as the mine life for Tropicana becomes clearer, McPhillamy's is showing some progress and Duketon looks better, all will provide further tailwinds.
A Buy rating is maintained. Price target $3.10.
This report was published on April 29, 2022.
Target price is $3.10 Current Price is $1.96 Difference: $1.14
If RRL meets the Shaw and Partners target it will return approximately 58% (excluding dividends, fees and charges).
Current consensus price target is $2.31, suggesting upside of 17.9%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 7.00 cents and EPS of 25.50 cents.
At the last closing share price the estimated dividend yield is 3.57%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.69.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 8.1, implying annual growth of -69.3%.
Current consensus DPS estimate is 1.7, implying a prospective dividend yield of 0.9%.
Current consensus EPS estimate suggests the PER is 24.2.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 7.00 cents and EPS of 30.80 cents.
At the last closing share price the estimated dividend yield is 3.57%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 6.36.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 16.8, implying annual growth of 107.4%.
Current consensus DPS estimate is 4.5, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 11.7.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
SES SECOS GROUP LIMITED
Paper & Packaging – Overnight Price: $0.18
Canaccord Genuity rates ((SES)) as Speculative Buy (1) –
Secos Group's Q3 FY22 sales and profit results came in below Canaccord Genuity's expectations.
Continued cost pressures and customer order delays were cited by the company's management as the reasons for the flagged net loss for FY22.
Canaccord Genuity's sales forecasts have been reduced by -9% and -21% for FY22 and FY23, respectively.
The broker has also reduced the margin forecasts and the profit momentum is now expected to return in FY23, underpinned by recent distribution agreements and increased manufacturing capacity.
The price target has been reduced to $0.29 from $0.40 and the rating has been reduced to Speculative Buy from Buy.
This report was published on April 27, 2022.
Target price is $0.29 Current Price is $0.18 Difference: $0.11
If SES meets the Canaccord Genuity target it will return approximately 61% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY21:
Canaccord Genuity forecasts a full year FY21 EPS of 0.00 cents.
Forecast for FY22:
Canaccord Genuity forecasts a full year FY22 EPS of 0.01 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 1800.00.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
SGR STAR ENTERTAINMENT GROUP LIMITED
Gaming – Overnight Price: $3.04
Goldman Sachs rates ((SGR)) as Neutral (3) –
Goldman Sachs lowers by -5% its FY23 earnings (EBITDA) estimate for Star Entertainment to reflect softer revenues and higher
compliance costs. Also, to account for the extended NSW regulatory inquiry process, the company's multiple is reduced.
As a result of these changes, the broker's target price falls to $3.75 from $4.10. As this amended target implies less than 20% upside from the latest share price, the Neutral rating is retained.
Nonetheless, the analyst remains positive on the stock in relation to management's initiatives around splitting the company in two to create a property company and an operating company.
This report was published on April 28, 2022.
Target price is $3.75 Current Price is $3.04 Difference: $0.71
If SGR meets the Goldman Sachs target it will return approximately 23% (excluding dividends, fees and charges).
Current consensus price target is $4.19, suggesting upside of 37.7%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Goldman Sachs forecasts a full year FY22 EPS of minus 2.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 152.00.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -2.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY23:
Goldman Sachs forecasts a full year FY23 EPS of 16.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.00.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 20.0, implying annual growth of N/A.
Current consensus DPS estimate is 12.9, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 15.2.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
SLA SILK LASER AUSTRALIA LIMITED
Healthcare services – Overnight Price: $2.68
Wilsons rates ((SLA)) as Overweight (1) –
Wilsons noted Silk Laser Australia's Q3 FY22 trading update showed network cash sales were up 91% to $116.9m, which was in-line if not slightly above the broker's expectations.
Silk Laser Australia's FY22 earnings guidance of at least $20m is consistent with Wilsons current forecast and the trading update confirmed that the company is on track to meet the broker's second half network sales.
The broker does not see any evidence that Silk should be grouped into a consumer discretionary retail spend category with no correlation between injectable (botox, fillers) procedure levels and/or spend declining during recessions (US data).
Silk will release the 3rd and final tranche of stock from voluntary escrow post the 2021 IPO at the August 2022 earnings result, representing 4.74m shares or 9% of the total shares on issue.
The broker's forecasts remain unchanged with a $5.25 price target and an Overweight rating.
This report was published on April 28, 2022.
Target price is $5.25 Current Price is $2.68 Difference: $2.57
If SLA meets the Wilsons target it will return approximately 96% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Wilsons forecasts a full year FY22 dividend of 0.00 cents and EPS of 15.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.18.
Forecast for FY23:
Wilsons forecasts a full year FY23 dividend of 0.00 cents and EPS of 23.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.55.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
SLH SILK LOGISTICS HOLDINGS LIMITED
Transportation & Logistics – Overnight Price: $2.50
Shaw and Partners rates ((SLH)) as Buy (1) –
Silk Logistics announced the completion of Kemps Creek, NSW, property novation post acquisition to ESR Australia noted Shaw and Partners.
Under the terms of the lease agreement ESR is responsible for the construction and associated building costs of the warehouses and SLH the fit-out works.
Shaw and Partners sees many positives from this announcement. The transaction de-risks the cash flows for the company, expands the capacity, reduces the costs and optimises the usage for Silk Logistics.
The broker considers the company as well positioned for long-term and profitable growth, with minimal debt and high management expertise.
The price target of $3.15 is considered as conservative by Shaw and Partners and the stock is a Buy rate.
This report was published on April 29, 2022.
Target price is $3.15 Current Price is $2.50 Difference: $0.65
If SLH meets the Shaw and Partners target it will return approximately 26% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 8.20 cents and EPS of 20.30 cents.
At the last closing share price the estimated dividend yield is 3.28%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.32.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 14.00 cents and EPS of 28.40 cents.
At the last closing share price the estimated dividend yield is 5.60%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.80.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
TAH TABCORP HOLDINGS LIMITED
Gaming – Overnight Price: $5.15
Goldman Sachs rates ((TAH)) as Buy (1) –
The latest domestic lottery trends suggest to Goldman Sachs a solid backdrop for the gaming industry with a strong positive read-through for Tabcorp.
The analyst expects a softer outcome for Gaming Services and Wagering for FY22-24, partly offset by better Lotteries momentum. As the group's earnings are skewed towards the Lottery business, the target price rises to $6.25 from $6.20.
The shift to higher-margin digital and an upcoming OzLotto game change should result in upside for Lotteries, explains the broker. The Buy rating is unchanged.
This report was published on April 28, 2022.
Target price is $6.25 Current Price is $5.15 Difference: $1.1
If TAH meets the Goldman Sachs target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $5.83, suggesting upside of 13.2%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Goldman Sachs forecasts a full year FY22 dividend of 15.00 cents and EPS of 18.00 cents.
At the last closing share price the estimated dividend yield is 2.91%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.61.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 17.3, implying annual growth of 40.4%.
Current consensus DPS estimate is 13.6, implying a prospective dividend yield of 2.6%.
Current consensus EPS estimate suggests the PER is 29.8.
Forecast for FY23:
Goldman Sachs forecasts a full year FY23 dividend of 18.70 cents and EPS of 23.00 cents.
At the last closing share price the estimated dividend yield is 3.63%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.39.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 21.4, implying annual growth of 23.7%.
Current consensus DPS estimate is 17.4, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 24.1.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
TSI TOP SHELF INTERNATIONAL HOLDINGS LIMITED
Food, Beverages & Tobacco – Overnight Price: $1.37
Moelis rates ((TSI)) as Buy rating (1) –
Top Shelf International's March-quarter trading update appears to have missed Moelis' forecasts, as sales failed to meet expectations, but pleased none-the-less.
The broker spies plenty of positives: national sales to Coles Liquor Group ((COL)) kicked in (product offering to expand in the June quarter); distribution agreements were signed with Independent Liquor Group, Local Liquor and Star Liquor Group; the company harvested its first whisky batch from the Campbellfield distillery; and investment in spirits inventory continued.
Net cash finished at $5.2m. The broker considers Top Shelf to be well positioned for long-term growth. Buy rating retained. Target price inches up to $2.05.
This report was published on May 1, 2022.
Target price is $2.05 Current Price is $1.37 Difference: $0.68
If TSI meets the Moelis target it will return approximately 50% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Moelis forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 35.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 3.83.
Forecast for FY23:
Moelis forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 20.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 6.68.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
WPR WAYPOINT REIT LIMITED
REITs – Overnight Price: $2.48
Goldman Sachs rates ((WPR)) as Buy (1) –
Waypoint REIT announced the sale of 29 assets to Fawkner Property for a combined $141.8m, with Goldman Sachs noting the sales comprises largely regional properties. The broker highlights the sale is in-line with guidance for $150m in asset sales in FY22.
The deal is conditional on a 30-day first right of refusal where either Viva Energy ((VEA)) or Coles Group ((COL)) can acquire the assets for the same conditions as agreed to by Fawkner Property.
According to Goldman Sachs, Waypoint REIT has taken advantage of recent strong demand to recycle non-core assets and drive gearing below its targeted 30-40%.
The Buy rating is retained with a target price of $3.16.
This report was published on April 27, 2022.
Target price is $3.16 Current Price is $2.48 Difference: $0.68
If WPR meets the Goldman Sachs target it will return approximately 27% (excluding dividends, fees and charges).
Current consensus price target is $2.92, suggesting upside of 17.9%(ex-dividends)
The company's fiscal year ends in December.
Forecast for FY22:
Goldman Sachs forecasts a full year FY22 dividend of 8.00 cents and EPS of 16.00 cents.
At the last closing share price the estimated dividend yield is 3.23%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.50.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 16.1, implying annual growth of -71.8%.
Current consensus DPS estimate is 16.4, implying a prospective dividend yield of 6.6%.
Current consensus EPS estimate suggests the PER is 15.4.
Forecast for FY23:
Goldman Sachs forecasts a full year FY23 dividend of 8.00 cents and EPS of 17.00 cents.
At the last closing share price the estimated dividend yield is 3.23%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.59.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 16.7, implying annual growth of 3.7%.
Current consensus DPS estimate is 16.9, implying a prospective dividend yield of 6.8%.
Current consensus EPS estimate suggests the PER is 14.9.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
WSP WHISPIR LIMITED
Cloud services – Overnight Price: $1.08
Canaccord Genuity rates ((WSP)) as Downgrade to Hold from Buy (3) –
Whispir's Q3 FY22 trading update showed annual recurring revenue up 24% on last year and up 4% on the last quarter, points out Canaccord Genuity.
The broker noted the run-rate growth is below the historical trend and the incremental Q3 annual recurring revenue growth of $2.4m was the lowest in the last seven quarters.
Canaccord Genuity has reduced the revenue forecasts -4% and -11% for FY22 and FY23, respectively, impacting on forward earnings estimates.
The price target has been reduced to $2.00 from $3.00 and the recommendation has been changed to Hold from Buy.
The broker would like to see an improvement in the average recurring revenue and a reduced cash burn before becoming more positive on the stock.
This report was published on April 28, 2022.
Target price is $2.00 Current Price is $1.08 Difference: $0.92
If WSP meets the Canaccord Genuity target it will return approximately 85% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Canaccord Genuity forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 7.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 14.40.
Forecast for FY23:
Canaccord Genuity forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 15.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 6.84.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Z2U ZOOM2U TECHNOLOGIES LIMITED
Transportation & Logistics – Overnight Price: $0.27
Shaw and Partners rates ((Z2U)) as Buy (1) –
Zoom2u Technologies released its Q3 FY22 trading update. Shaw and Partners noted strong growth in revenue and gross merchandise value (GMV) in a seasonally quieter quarter, continued momentum in customer additions and a number of enterprises trialing the company's platform.
The company reported very strong cash flow receipts due to a decrease in debtors. Cash costs were marginally higher due to increased advertising and product manufacturing costs, the broker noted.
Shaw and Partners maintains the $0.45 price target and a Buy rating.
This report was published on April 29, 2022.
Target price is $0.45 Current Price is $0.27 Difference: $0.18
If Z2U meets the Shaw and Partners target it will return approximately 67% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Shaw and Partners forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 2.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 12.86.
Forecast for FY23:
Shaw and Partners forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 1.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 18.00.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
As part of emerging new trends overseas, The Australian Broker Call *Extra* Edition also includes providers of sponsored research. Readers should bear in mind, sponsored research, while not necessarily of lower quality, has the embedded complication that the company that is the subject of the research has paid for this research. Providers of sponsored research that can potentially be included in this Report are Breakaway Research, Edison Investment Research, Independent Investment Research, NDF Research, Pitt Street Research, and TMT Analytics.
Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: ABY - ADORE BEAUTY GROUP LIMITED
For more info SHARE ANALYSIS: AD8 - AUDINATE GROUP LIMITED
For more info SHARE ANALYSIS: ALC - ALCIDION GROUP LIMITED
For more info SHARE ANALYSIS: ALL - ARISTOCRAT LEISURE LIMITED
For more info SHARE ANALYSIS: AT1 - ATOMO DIAGNOSTICS LIMITED
For more info SHARE ANALYSIS: AX1 - ACCENT GROUP LIMITED
For more info SHARE ANALYSIS: B4P - BEFOREPAY GROUP LIMITED
For more info SHARE ANALYSIS: BET - BETMAKERS TECHNOLOGY GROUP LIMITED
For more info SHARE ANALYSIS: CLU - CLUEY LIMITED
For more info SHARE ANALYSIS: COF - CENTURIA OFFICE REIT
For more info SHARE ANALYSIS: COH - COCHLEAR LIMITED
For more info SHARE ANALYSIS: COL - COLES GROUP LIMITED
For more info SHARE ANALYSIS: CRN - CORONADO GLOBAL RESOURCES INC
For more info SHARE ANALYSIS: CUV - CLINUVEL PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: FCL - FINEOS CORPORATION HOLDINGS PLC
For more info SHARE ANALYSIS: FMG - FORTESCUE LIMITED
For more info SHARE ANALYSIS: GOR - GOLD ROAD RESOURCES LIMITED
For more info SHARE ANALYSIS: GOZ - GROWTHPOINT PROPERTIES AUSTRALIA
For more info SHARE ANALYSIS: IPD - IMPEDIMED LIMITED
For more info SHARE ANALYSIS: JIN - JUMBO INTERACTIVE LIMITED
For more info SHARE ANALYSIS: KED - KEYPATH EDUCATION INTERNATIONAL INC
For more info SHARE ANALYSIS: NCM - NEWCREST MINING LIMITED
For more info SHARE ANALYSIS: NST - NORTHERN STAR RESOURCES LIMITED
For more info SHARE ANALYSIS: NWS - NEWS CORPORATION
For more info SHARE ANALYSIS: NXS - NEXT SCIENCE LIMITED
For more info SHARE ANALYSIS: OPY - OPENPAY GROUP LIMITED
For more info SHARE ANALYSIS: PBH - POINTSBET HOLDINGS LIMITED
For more info SHARE ANALYSIS: PDN - PALADIN ENERGY LIMITED
For more info SHARE ANALYSIS: PLL - PIEDMONT LITHIUM INC
For more info SHARE ANALYSIS: QML - QMINES LIMITED
For more info SHARE ANALYSIS: REA - REA GROUP LIMITED
For more info SHARE ANALYSIS: RMS - RAMELIUS RESOURCES LIMITED
For more info SHARE ANALYSIS: RRL - REGIS RESOURCES LIMITED
For more info SHARE ANALYSIS: SES - SECOS GROUP LIMITED
For more info SHARE ANALYSIS: SGR - STAR ENTERTAINMENT GROUP LIMITED
For more info SHARE ANALYSIS: SLA - SILK LASER AUSTRALIA LIMITED
For more info SHARE ANALYSIS: SLH - SILK LOGISTICS HOLDINGS LIMITED
For more info SHARE ANALYSIS: TAH - TABCORP HOLDINGS LIMITED
For more info SHARE ANALYSIS: TSI - TOP SHELF INTERNATIONAL HOLDINGS LIMITED
For more info SHARE ANALYSIS: VEA - VIVA ENERGY GROUP LIMITED
For more info SHARE ANALYSIS: WPR - WAYPOINT REIT LIMITED
For more info SHARE ANALYSIS: WSP - WHISPIR LIMITED
For more info SHARE ANALYSIS: Z2U - ZOOM2U TECHNOLOGIES LIMITED